Boulder-based MBio Diagnostics closes $6.3M Series B funding round

BOULDER — MBio Diagnostics Inc. announced Thursday that it has closed a $6.3 million round of Series B funding that will be used to advance work on a portable diagnostic tool that can detect proteins, cells, nucleic acids and small molecules in minutes.

The Boulder-based medical-device company received the funding from new and existing private investors, according to a company statement. A spokeswoman for MBio said the company is not releasing the names of the investors of this round.

The funding will be used to refine the platform and improve manufacturing of its MBio Array System, as well as help the company…